Largest pharmaceuticals by net assets
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Pfizer leads the 61 pharmaceuticals ranked by net assets, at CZK 1.92T, ahead of Johnson & Johnson (CZK 1.81T) and Sanofi (CZK 1.76T). Figures as of 18 Nov 2026, 14:30 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- PfizerCZK 1.92T
- Median
- CZK 19.5B
- Combined market value
- CZK 114.09T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Net assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | PfizerPFE · Health Care | CZK 1.92T | CZK 3.57T | CZK 625.59 | 1.12% down | 14% up | ||
| 2 | Johnson & JohnsonJNJ · Health Care | CZK 1.81T | CZK 14.79T | CZK 6,143.29 | 0.89% down | 38% up | ||
| 3 | SanofiSNY · Health Care | CZK 1.76T | CZK 2.53T | CZK 1,053.76 | 0.27% down | 4% down | ||
| 4 | Merck & CoMRK · Health Care | CZK 1.17T | CZK 7.86T | CZK 3,187.30 | 0.75% down | 51% up | ||
| 5 | Abbott LaboratoriesABT · Health Care | CZK 1.16T | CZK 4.03T | CZK 2,327.84 | 2.55% down | 17% down | ||
| 6 | AstraZenecaAZN · Health Care | CZK 1.08T | CZK 6.2T | CZK 3,999.44 | 1.27% down | 2% up | ||
| 7 | Takeda PharmaceuticalTAK · Health Care | CZK 1.03T | CZK 1.54T | CZK 481.09 | 0.23% up | 54% up | ||
| 8 | NovartisNVS · Health Care | CZK 1.03T | CZK 6.6T | CZK 3,492.09 | 1.31% down | 25% up | ||
| 9 | Regeneron PharmaceuticalsREGN · Health Care | CZK 694.9B | CZK 2.2T | CZK 21,292.25 | 0.56% up | 36% up | ||
| 10 | Novo NordiskNVO · Health Care | CZK 640.2B | CZK 3.93T | CZK 892.81 | 1.34% down | 17% down | ||
| 11 | Eli LillyLLY · Health Care | CZK 589.9B | CZK 28.03T | CZK 31,469.52 | 1.13% down | 35% up | ||
| 12 | GSKGSK · Health Care | CZK 483.3B | CZK 2.18T | CZK 1,088.56 | 0.53% down | 6% up | ||
| 13 | Vertex PharmaceuticalsVRTX · Health Care | CZK 415B | CZK 3.01T | CZK 11,875.96 | 0.67% down | 27% up | ||
| 14 | Bristol-Myers SquibbBMY · Health Care | CZK 410.7B | CZK 2.76T | CZK 1,350.77 | 1.01% down | 34% up | ||
| 15 | ViatrisVTRS · Health Care | CZK 327.1B | CZK 521.2B | CZK 454.63 | 1.40% down | 96% up | ||
| 16 | Royalty PharmaRPRX · Health Care | CZK 216B | CZK 877.9B | CZK 1,526.85 | 0.23% up | 78% up | ||
| 17 | Teva Pharmaceutical IndustriesTEVA · Health Care | CZK 175.8B | CZK 1.11T | CZK 950.83 | 0.38% up | 74% up | ||
| 18 | United TherapeuticsUTHR · Health Care | CZK 157.8B | CZK 553B | CZK 12,985.30 | 0.64% down | 23% up | ||
| 19 | Elanco Animal HealthELAN · Health Care | CZK 145.5B | CZK 286.1B | CZK 572.46 | 0.39% down | 20% up | ||
| 20 | BioMarin PharmaceuticalBMRN · Health Care | CZK 135.3B | CZK 251.9B | CZK 1,300.75 | 0.90% up | 11% up | ||
| 21 | GrifolsGRFS · Health Care | CZK 130B | CZK 130.6B | CZK 191.86 | 1.15% down | 1% up | ||
| 22 | GenmabGMAB · Health Care | CZK 130B | CZK 707.6B | CZK 1,147.58 | 0.65% down | 70% up | ||
| 23 | Roivant SciencesROIV · Health Care | CZK 100.6B | CZK 623.5B | CZK 860.57 | 0.26% up | 90% up | ||
| 24 | BeOne MedicinesONC · Health Care | CZK 97B | CZK 1.05T | CZK 9,187.31 | 0.48% up | 17% up | ||
| 25 | Jazz PharmaceuticalsJAZZ · Health Care | CZK 96B | CZK 343B | CZK 5,343.07 | 0.15% down | 37% up | ||
| 26 | Dr. Reddy's LaboratoriesRDY · Health Care | CZK 89.2B | CZK 274.1B | CZK 328.80 | 0.61% up | 5% up | ||
| 27 | ZoetisZTS · Health Care | CZK 74.1B | CZK 743.6B | CZK 1,830.19 | 1.38% down | 29% down | ||
| 28 | AlkermesALKS · Health Care | CZK 40.4B | CZK 169.8B | CZK 1,010.41 | 2.32% down | 58% up | ||
| 29 | Ligand PharmaceuticalsLGND · Health Care | CZK 22.6B | CZK 131.2B | CZK 6,558.23 | 0.41% up | 43% up | ||
| 30 | Legend BiotechLEGN · Health Care | CZK 22.3B | CZK 69.5B | CZK 358.15 | 0.75% up | 42% down | ||
| 31 | Praxis Precision MedicinesPRAX · Health Care | CZK 19.5B | CZK 189.6B | CZK 6,781.88 | 1.68% down | 61% up | ||
| 32 | Alnylam PharmaceuticalsALNY · Health Care | CZK 17.5B | CZK 461.5B | CZK 3,445.85 | 0.96% down | 66% down | ||
| 33 | Belite BioBLTE · Health Care | CZK 17.1B | CZK 142.4B | CZK 3,506.32 | 2.98% down | 31% up | ||
| 34 | InsmedINSM · Health Care | CZK 16.4B | CZK 594.3B | CZK 2,709.11 | 0.83% down | 40% down | ||
| 35 | Spyre TherapeuticsSYRE · Health Care | CZK 15.9B | CZK 198.1B | CZK 2,085.52 | 5.60% down | 286% up | ||
| 36 | Summit TherapeuticsSMMT · Health Care | CZK 14.6B | CZK 182.1B | CZK 227.65 | 4.03% down | 36% down | ||
| 37 | TG TherapeuticsTGTX · Health Care | CZK 14.4B | CZK 210.7B | CZK 1,394.12 | 0.08% down | 107% up | ||
| 38 | Corcept TherapeuticsCORT · Health Care | CZK 14.4B | CZK 170.5B | CZK 1,557.75 | 1.23% up | 8% down | ||
| 39 | Cogent BiosciencesCOGT · Health Care | CZK 14.1B | CZK 107.7B | CZK 619.14 | 1.49% up | 20% down | ||
| 40 | Protagonist TherapeuticsPTGX · Health Care | CZK 13.7B | CZK 180.9B | CZK 2,771.58 | 0.13% down | 46% up | ||
| 41 | Madrigal PharmaceuticalsMDGL · Health Care | CZK 13.4B | CZK 217.9B | CZK 9,381.39 | 0.46% down | 24% down | ||
| 42 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | CZK 12.6B | CZK 166.1B | CZK 2,114.42 | 0.93% up | 126% up | ||
| 43 | Edgewise TherapeuticsEWTX · Health Care | CZK 11.6B | CZK 102.3B | CZK 934.60 | 3.75% down | 88% up | ||
| 44 | ABIVAXABVX · Health Care | CZK 11.2B | CZK 159.8B | CZK 1,825.19 | 1.81% down | 27% down | ||
| 45 | Dianthus TherapeuticsDNTH · Health Care | CZK 11B | CZK 108.9B | CZK 1,933.68 | 2.87% down | 113% up | ||
| 46 | Ionis PharmaceuticalsIONS · Health Care | CZK 10.9B | CZK 99.8B | CZK 599.36 | 3.75% down | 64% down | ||
| 47 | Oruka TherapeuticsORKA · Health Care | CZK 10.5B | CZK 145.2B | CZK 2,141.32 | 2.94% down | 241% up | ||
| 48 | Arrowhead PharmaceuticalsARWR · Health Care | CZK 10.4B | CZK 135.1B | CZK 955.72 | 2.76% down | 10% up | ||
| 49 | Definium TherapeuticsDFTX · Health Care | CZK 7.4B | CZK 89.4B | CZK 653.16 | 2.59% down | 169% up | ||
| 50 | ErascaERAS · Health Care | CZK 7.2B | CZK 108.4B | CZK 308.79 | 8.07% down | 403% up | ||
| 51 | Mirum PharmaceuticalsMIRM · Health Care | CZK 7B | CZK 133.4B | CZK 2,044.17 | 0.40% up | 31% up | ||
| 52 | Rhythm PharmaceuticalsRYTM · Health Care | CZK 3.1B | CZK 179.7B | CZK 2,592.39 | 8.49% up | 13% up | ||
| 53 | Travere TherapeuticsTVTX · Health Care | CZK 2.6B | CZK 109B | CZK 1,136.02 | 2.82% up | 44% up | ||
| 54 | Axsome TherapeuticsAXSM · Health Care | CZK 2B | CZK 159B | CZK 3,022.35 | 0.77% down | 7% down | ||
| 55 | Amneal PharmaceuticalsAMRX · Health Care | -CZK 1.6B | CZK 163.6B | CZK 469.53 | 0.52% down | 83% up | ||
| 56 | VeradermicsMANE · Health Care | -CZK 2.7B | CZK 117.9B | CZK 2,793.14 | 1.88% down | 233% up | ||
| 57 | Ascendis PharmaASND · Health Care | -CZK 4B | CZK 392.3B | CZK 5,980.66 | 0.80% down | 28% up | ||
| 58 | PTC TherapeuticsPTCT · Health Care | -CZK 4.6B | CZK 112.1B | CZK 1,341.88 | 1.00% down | 20% down | ||
| 59 | CytokineticsCYTK · Health Care | -CZK 14.7B | CZK 158.9B | CZK 1,140.47 | 0.68% down | 20% down | ||
| 60 | BridgeBio PharmaBBIO · Health Care | -CZK 46.4B | CZK 332.6B | CZK 1,707.36 | 0.72% down | 17% up | ||
| 61 | AbbVieABBV · Health Care | -CZK 72.7B | CZK 11.38T | CZK 6,440.85 | 1.07% down | 26% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 22.2313 CZK).
Questions and answers
Which pharmaceuticals rank first by net assets?
Pfizer (CZK 1.92T), Johnson & Johnson (CZK 1.81T) and Sanofi (CZK 1.76T) are the top three of the 61 pharmaceuticals ranked by net assets as of 18 Nov 2026, 14:30 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by net assets.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by net assets have a combined market value of CZK 114.09T as of 18 Nov 2026, 14:30 UTC.
What does ranking by net assets measure?
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceuticals by net assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=net-assets
Underlying data: Yahoo Finance; SEC EDGAR.